SurrogateBMA (Q5977130): Difference between revisions
From MaRDI portal
Changed an Item |
Changed an Item |
||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI software profile / rank | |||
Normal rank |
Revision as of 14:09, 7 March 2024
Flexible Evaluation of Surrogate Markers with Bayesian Model Averaging
Language | Label | Description | Also known as |
---|---|---|---|
English | SurrogateBMA |
Flexible Evaluation of Surrogate Markers with Bayesian Model Averaging |
Statements
Provides functions to estimate the proportion of treatment effect explained by the surrogate marker using a Bayesian Model Averaging approach. Duan and Parast (2023) <doi:10.1002/sim.9986>.
0 references
1 February 2024
0 references
expanded from: GPL (≥ 2) (English)
0 references